← Open Payments lookup

ALICE GERMAINE BEUKAM: Open Payments

NPI 1760152763 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$402 in 17 payments from 9 companies in 2025. Trend: 2023 $602 · 2024 $1,326 · 2025 $402

Food & beverage: $402
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$136
E.R. Squibb & Sons, L.L.C.5$88
Lundbeck LLC3$66
ABBVIE INC.1$23
Alkermes, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$18
Otsuka Pharmaceutical Development & Commercialization, Inc.1$18
Indivior Inc.1$17
Supernus Pharmaceuticals, Inc.1$16

Products named: INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, SUBLOCADE, Qelbree.

Industry payments across DC — which companies pay providers there.